Detalhe da pesquisa
1.
Long-term progression-free survival in patients with chronic lymphocytic leukemia treated with novel agents: An analysis based on indirect comparisons.
Eur J Haematol
; 110(1): 60-66, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193009
2.
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.
World J Urol
; 40(11): 2609-2615, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083316
3.
Evaluation of maintenance treatment with PARP inhibitors in ovarian carcinoma patients responding to platinum therapy: Use of restricted mean survival time as an index of efficacy.
Int J Clin Pharmacol Ther
; 60(1): 32-35, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779394
4.
Medical therapy, radiofrequency ablation or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through restricted mean survival time and network meta-analysis.
Rev Cardiovasc Med
; 22(3): 557-561, 2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34565059
5.
First-line treatments for chronic lymphocytic leukemia: Analysis of 7 trials based on the restricted mean survival time.
Int J Clin Pharmacol Ther
; 59(4): 322-327, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300864
6.
Trastuzumab biosimilar in metastatic breast cancer: Evaluating equivalence with originator using network meta-analysisâ©.
Int J Clin Pharmacol Ther
; 57(3): 160-162, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30574866
7.
Inhibitors in Hemophilia A: A Pharmacoeconomic Perspective.
Semin Thromb Hemost
; 44(6): 561-567, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29220854
8.
Meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data.
Ann Hematol
; 102(6): 1603-1605, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877260
9.
Letter by Ferracane et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
Circulation
; 143(6): e232-e233, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555923
10.
"Total evidence" network meta-analysis as a tool for improving the assessment of biosimilars: application to etanercept in rheumatoid arthritisâ©.
Int J Clin Pharmacol Ther
; 55(6): 517-520, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28372634
11.
Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy.
Int J Clin Pharmacol Ther
; 60(8): 370-372, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652551
12.
Implant-based breast reconstruction: re-analysis of the odds ratio for skin flap necrosis.
Breast Cancer Res Treat
; 185(3): 887, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33225413
13.
Evolocumab and alirocumab: exploring original procurement models to manage the reimbursement of these innovative treatments.
Int J Clin Pharmacol Ther
; 54(10): 771-4, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27117037
14.
Targeted Treatments for Pulmonary Arterial Hypertension: Interpreting Outcomes by Network Meta-analysis.
Heart Lung Circ
; 25(1): 46-52, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26233257
15.
16.
First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis.
Ann Hematol
; 94(6): 1003-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25677267
17.
Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median.
Acta Haematol
; 143(6): 598-599, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32074609
18.
Testing the therapeutic equivalence of novel oral anticoagulants for thromboprophylaxis in orthopedic surgery and for prevention of stroke in atrial fibrillation.
Int J Clin Pharmacol Ther
; 53(3): 211-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25295718
19.
The safety of bevacizumab and ranibizumab in clinical studies.
Int Ophthalmol
; 35(2): 157-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646753
20.
Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods.
J Endocrinol Invest
; 37(8): 769-773, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25008458